Duopharma Biotech Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,241	1,202	1,202	1,212	1,533	1,582
Market Cap Growth	7.50%	-	-0.79%	-20.94%	-3.10%	-33.70%
Enterprise Value	1,452	1,428	1,469	1,522	1,819	1,881
Last Close Price	1.29	1.22	1.19	1.17	1.47	1.51
PE Ratio	13.42	13.75	19.19	23.02	21.87	24.09
Forward PE	12.10	12.08	14.74	14.77	15.91	20.97
PS Ratio	1.35	1.29	1.48	1.72	2.20	2.48
PB Ratio	1.64	1.59	1.70	1.76	2.34	2.54
P/TBV Ratio	1.72	1.60	1.71	1.78	2.35	2.56
P/FCF Ratio	16.80	15.03	20.12	76.43	301.61	-
P/OCF Ratio	12.53	11.26	14.43	24.84	21.82	36.62
PEG Ratio	0.91	0.61	0.72	12.31	1.10	4.11
EV/Sales Ratio	1.58	1.53	1.81	2.16	2.61	2.94
EV/EBITDA Ratio	8.07	8.35	10.70	13.35	14.80	16.36
EV/EBIT Ratio	10.40	10.67	14.66	19.34	19.57	21.19
EV/FCF Ratio	19.66	17.85	24.59	95.99	357.77	-
Debt / Equity Ratio	0.64	0.66	0.73	0.80	0.66	0.65
Debt / EBITDA Ratio	2.68	2.84	3.66	4.67	3.41	3.41
Debt / FCF Ratio	6.53	6.20	8.63	34.61	84.91	-
Net Debt / Equity Ratio	0.28	0.27	0.35	0.41	0.42	0.43
Net Debt / EBITDA Ratio	1.20	1.20	1.83	2.44	2.23	2.31
Net Debt / FCF Ratio	2.86	2.57	4.20	17.55	53.90	-4.02
Asset Turnover	0.64	0.66	0.60	0.55	0.58	0.57
Inventory Turnover	2.03	2.10	2.08	1.83	1.82	2.06
Quick Ratio	1.68	1.66	2.65	2.59	1.13	1.18
Current Ratio	2.62	2.60	4.08	4.06	2.05	2.15
Return on Equity (ROE)	12.60%	11.93%	8.97%	7.84%	10.96%	10.36%
Return on Assets (ROA)	6.13%	5.91%	4.60%	3.83%	4.87%	4.99%
Return on Invested Capital (ROIC)	11.00%	10.59%	8.15%	6.91%	8.44%	8.37%
Return on Capital Employed (ROCE)	12.30%	11.80%	8.40%	6.70%	9.70%	9.50%
Earnings Yield	7.46%	7.27%	5.21%	4.34%	4.57%	4.15%
FCF Yield	5.95%	6.65%	4.97%	1.31%	0.33%	-4.18%
Dividend Yield	3.50%	3.72%	2.52%	1.96%	1.56%	1.44%
Payout Ratio	47.30%	38.49%	42.99%	16.81%	11.70%	68.45%
Buyback Yield / Dilution	-0.08%	-	-0.36%	-1.08%	-2.15%	-0.02%
Total Shareholder Return	3.42%	3.72%	2.16%	0.89%	-0.59%	1.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.